131 related articles for article (PubMed ID: 7553968)
1. N-alkylated 1,4-dihydropyridines: new agents to overcome multidrug resistance.
Ohsumi K; Ohishi K; Morinaga Y; Nakagawa R; Suga Y; Sekiyama T; Akiyama Y; Tsuji T; Tsuruo T
Chem Pharm Bull (Tokyo); 1995 May; 43(5):818-28. PubMed ID: 7553968
[TBL] [Abstract][Full Text] [Related]
2. Activities of newly synthesized dihydropyridines in overcoming of vincristine resistance, calcium antagonism, and inhibition of photoaffinity labeling of P-glycoprotein in rodents.
Kiue A; Sano T; Suzuki K; Inada H; Okumura M; Kikuchi J; Sato S; Kohno K; Kuwano M
Cancer Res; 1990 Jan; 50(2):310-7. PubMed ID: 1967223
[TBL] [Abstract][Full Text] [Related]
3. Circumvention of multidrug resistance by a newly synthesized quinoline derivative, MS-073.
Sato W; Fukazawa N; Suzuki T; Yusa K; Tsuruo T
Cancer Res; 1991 May; 51(9):2420-4. PubMed ID: 1673087
[TBL] [Abstract][Full Text] [Related]
4. In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52.
Shinoda H; Inaba M; Tsuruo T
Cancer Res; 1989 Apr; 49(7):1722-6. PubMed ID: 2924316
[TBL] [Abstract][Full Text] [Related]
5. Reversal by two dihydropyridine compounds of resistance to multiple anticancer agents in mouse P388 leukemia in vivo and in vitro.
Kiue A; Sano T; Naito A; Inada H; Suzuki K; Okumura M; Kikuchi J; Sato S; Takano H; Kohno K
Jpn J Cancer Res; 1990 Oct; 81(10):1057-64. PubMed ID: 1977728
[TBL] [Abstract][Full Text] [Related]
6. Newly synthesized dihydropyridine derivatives as modulators of P-glycoprotein-mediated multidrug resistance.
Tanabe H; Tasaka S; Ohmori H; Gomi N; Sasaki Y; Machida T; Iino M; Kiue A; Naito S; Kuwano M
Bioorg Med Chem; 1998 Nov; 6(11):2219-27. PubMed ID: 9881113
[TBL] [Abstract][Full Text] [Related]
7. In vivo reversal of multidrug resistance by two new dihydropyridine derivatives, S16317 and S16324.
Kraus-Berthier L; Guilbaud N; Peglion JL; Leonce S; Lombet A; Pierre A; Atassi G
Acta Oncol; 1994; 33(6):631-7. PubMed ID: 7946440
[TBL] [Abstract][Full Text] [Related]
8. Reversal of multidrug resistance by a novel quinoline derivative, MS-209.
Sato W; Fukazawa N; Nakanishi O; Baba M; Suzuki T; Yano O; Naito M; Tsuruo T
Cancer Chemother Pharmacol; 1995; 35(4):271-7. PubMed ID: 7828268
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure--activity analysis of novel dihydropyridine derivatives to overcome multidrug resistance.
Tasaka S; Ohmori H; Gomi N; Iino M; Machida T; Kiue A; Naito S; Kuwano M
Bioorg Med Chem Lett; 2001 Jan; 11(2):275-7. PubMed ID: 11206476
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of combination of antitumor agent with AHC-52 against multidrug-resistant cells in the intravenously inoculated P388 leukemia model.
Shinoda H; Ebisu H; Mitsuhashi J; Inaba M; Tsuruo T
Cancer Chemother Pharmacol; 1992; 30(5):335-40. PubMed ID: 1505070
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of the vincristine effect on P388 mouse leukemia cells by a newly synthesized dihydropyridine analogue, PAK-200.
Shudo N; Fujii R; Matsumoto T; Mizoguchi T; Seto K; Sakoda R; Akiyama S
Jpn J Cancer Res; 1992 Sep; 83(9):1011-7. PubMed ID: 1429198
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.
Tsuruo T; Iida H; Yamashiro M; Tsukagoshi S; Sakurai Y
Biochem Pharmacol; 1982 Oct; 31(19):3138-40. PubMed ID: 7150340
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of antitumour activity of etoposide by dihydropyridines on drug-sensitive and drug-resistant leukaemia in mice.
Kiue A; Sano T; Naito A; Okumura M; Kohno K; Kuwano M
Br J Cancer; 1991 Aug; 64(2):221-6. PubMed ID: 1892749
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of etoposide and vincristine by two synthetic 1,4-dihydropyridine derivatives in multidrug-resistant and atypical multidrug-resistant human cancer cells.
Watanabe Y; Takano H; Kiue A; Kohno K; Kuwano M
Anticancer Drug Des; 1991 Feb; 6(1):47-57. PubMed ID: 2015041
[TBL] [Abstract][Full Text] [Related]
15. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.
Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
Cancer Res; 1981 May; 41(5):1967-72. PubMed ID: 7214365
[TBL] [Abstract][Full Text] [Related]
16. Overcoming drug resistance in cancer cells with synthetic isoprenoids.
Yamaguchi T; Nakagawa M; Shiraishi N; Yoshida T; Kiyosue T; Arita M; Akiyama S; Kuwano M
J Natl Cancer Inst; 1986 May; 76(5):947-53. PubMed ID: 3457980
[TBL] [Abstract][Full Text] [Related]
17. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
Tsuruo T; Iida H; Kitatani Y; Yokota K; Tsukagoshi S; Sakurai Y
Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192
[TBL] [Abstract][Full Text] [Related]
18. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
[TBL] [Abstract][Full Text] [Related]
19. A benzophenazine derivative, N-beta-dimethylaminoethyl 9-carboxy-5-hydroxy-10-methoxy-benzo[a]phenazine-6-carboxamide, as a new antitumor agent against multidrug-resistant and sensitive tumors.
Tsuruo T; Naito M; Takamori R; Tsukahara S; Yamabe-Mitsuhashi J; Yamazaki A; Oh-hara T; Sudo Y; Nakaike S; Yamagishi T
Cancer Chemother Pharmacol; 1990; 26(2):83-7. PubMed ID: 2161296
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of antitumor and antimetastatic activities of adriamycin by a novel N-alkylated dihydropyridine, AC394, and its enantiomers in colon cancer-bearing mice.
Ohishi K; Morinaga Y; Ohsumi K; Nakagawa R; Suga Y; Tsuji T; Akiyama Y; Tsuruo T
Cancer Chemother Pharmacol; 1996; 38(5):446-52. PubMed ID: 8765438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
